News | December 27, 2024
Mankind Pharma and Innovent Biologics join forces for cancer care with Sintilimab
Mankind Pharma will have exclusive rights to register, import, market, sell and distribute sintilimab in India
Mankind Pharma will have exclusive rights to register, import, market, sell and distribute sintilimab in India
The transaction is expected to result in approximately $175 million to support further development of IMG-007
Aims to become India’s leading cancer testing company
The offer price is approximately 4.32% below the closing price of the Merck common stock on November 11, 2024
The Scheme is subject to approval of the secured creditors and shareholders of TML and GTBL
Construction of the plant will commence in 2025 with first production expected to be in 2027
_256_384.jpg)
Tyvek with Renewable Attribution is designed to help reduce the carbon footprint
Revenue at Rs 3,623 crore, EBITDA at Rs 718 crore
ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure
Buckley served as Chairman and Chief Executive Officer at Vanguard from 2018 until his retirement in 2024
Subscribe To Our Newsletter & Stay Updated
